Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001800934-22-000001
Filing Date
2022-03-23
Accepted
2022-03-23 13:18:16
Documents
1
Effectiveness Date
2022-03-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6598
  Complete submission text file 0001800934-22-000001.txt   7623
Mailing Address 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address 953 INDIANA STREET SAN FRANCISCO CA 94107 217-766-4292
Revel Pharmaceuticals Inc. (Filer) CIK: 0001800934 (see all company filings)

EIN.: 842338101 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-438594 | Film No.: 22762690